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   To find a new contrast medium which provides to isobutyl cyanoacrylate (IBCA) an appropriate set 
time in blood, viscosity and radiopacity, new materials for therapeutic embolization have been prepared 
by mixing IBCA with perbromoperfluorocarbons (BPFC) at varying compositions. BPFC used in this 
work include hexafluorodibromopropane (FPB2) and tetrafluorodibromoethane (FEB2): Although mix-
ing of conventional contrast media (lipiodol and iophendylate) with IBCA leads to an increase in the 
viscosity and the set time in blood, the new mixtures from BPFC reveal fairly low viscosities and quite 
short set times. X-ray observation shows that the 5:5 mixture of IBCA and BPFC is satisfactory with 
radiopacity. Furthermore, BPFC exhibits insignificant toxicity in an acute test with mice by oral 
administration. Consequently, the newly prepared materials seem very promising for clinical applica-
tions as radiopaque embolization materials. 
     KEY WORDS: Cyanoacrylate/ Embolization/ Contrast medium/ Arteriove-
                  nous malformation/ 
                         INTRODUCTION 
    Cerebral vascular anomalies such as cerebral arteriovenous malformations (AVM) 
and cerebral arteriovenous fistulas have been menaces to human Mel). Surgical 
resection and therapeutic embolization are the only ways of treatment for these 
diseases. The therapeutic embolization of cerebral vascular lesions with 2-
cyanoacrylates (CA), which are known as surgical adhesives, is currently a relatively 
common clinical procedure 2-7). As the anomalies can be completely embolized by 
deposition of CA within the nidus of the lesion, the therapeutic embolization with CA is 
considered as more effective treatment than that using solid embolizing substances such 
as silicone and spocell® which are used as proximal occlusion of cerebral vascular 
anomalies. 
   The embolization with CA is generally carried out either by femoral approach or 
by craniotomy. In the former case, in which CA is injected through a balloon catheter 
to the nidus of lesion, a contrast medium should be added to CA which lacks in 
radiopacity. As CA is hydrophobic, the contrast medium should be also lipophilic so 
as to be dissolved in CA. In addition, the contrast medium must be stable in CA and 
should not interfere with polymerization of CA. Very few lipophilic contrast media are 
available at present. Among them are lipiodol and iophendylate. However, when 
they are mixed with CA, its polymerization time becomes very long and its viscosity 
becomes very high. Prolonged polymerization may bring about flowing-down of the 
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mixture to unexpected places before complete polymerization. High viscosity of the 
mixture may cause breakage of the superselective catheter or uncomplete obliteration of 
nidus due to an insufficient amount of the embolus agent. 
   The present work was undertaken to study whether perbromoperfluorocarbons 
(BPFC) added to isobutyl cyanoacrylate (IBCA) could be new contrast media to solve 
all these problems. 
                        EXPERIMENTAL 
   IBCA was synthesized with the conventional method from isobutyl cyanoacetate 
and  paraformaldehyde. BPFC were supplied by Daikin Industries LDT., Osaka, 
Japan. The chemical structure and the boiling point of BPFC are given in Fig. 1. A 
commercial contrast medium, lipiodol ultrafluide (lipiodol) was used for comparison. 
Tetrafluorodibromoefhane ( FEB2 ) 
CF2BrCF2Brbp.47°C 
Hexafluorodibromopropane ( FPB2 ) 
                    CF3 CFBr CF2 Br bp.70°C
(FOB) 
C8 F17Br bp.142°C 
              Figure 1. Chemical structure of perbromoperfluorocarbons (BPFC). 
   Viscosities of the mixtures of IBCA with the contrast media were measured by a 
rotational viscometer (Tokyo Keiki Co., LTD., Japan) at 25°C. Set times of the 
mixtures in blood were determined by dropping 10 pl of the mixtures from a height of 9 
mm on fresh canine blood which was placed in 41 mm Petri dish to 7 mm depth, 
followed by measuring the period of time just from the contacting moment of the 
mixtures on the blood surface to that of the complete opacification at 25°C9). The set 
time was then determined by averaging fifteen readings. The set times of the mixtures 
in vitro were determined according to the following procedure. After the surface of 
stainless steel test strips (16 X 25X 100 mm3) was polished with a 240 number sand 
paper, rinsed rigorously with acetone, and dried at 50°C for 4 hours, they were kept at 
60% RH and 25°C overnight. After applying 10 ,a l of the mixtures to the adhesion 
surface in accordance with JISK 6861-77, a weight of 5 kg was hung on the end of the 
bonded test strips in a certain time period, while the other ;end of the bonded test strips 
was fixed. The set time was then determined as the duration from the start until to the 
monent when adhesion fracture occurred. Ten measurements were made to obtain the 
average value. JCL-ICR mice were used for acute tests of BPFC by oral administra-
tion. Angiography of the embolus agent was carried out using mongrel dogs. 
( 233 )
             Y.-C. TSENG,  S.-H. HYON, Y. IKADA, W. TAKI, A. UNO and Y. YONEKAWA 
                           RESULTS 
Solubility 
   Both tetrafluorodibromoethane (FEB2) and hexafluorodibromopropane (FPB2) 
were miscible with IBCA in all proportions, while the mixture of IBCA with 
perfluorooctybromide (FOB) which had the highest molecular weight among BPFC, 
was separated into two phases within a few minutes. Therefore, the latter was not 
studied any more in this work. 
Viscosity 
   The viscosities of the IBCA-BPFC mixtures as well as the IBCA-lipiodol mixtures 
are shown in Fig. 2. The lipiodol itself has a high viscosity such as 35 cP, while the 
viscosity of FEB2 and FPB2 is both only 2.5 cP. The viscosity of the IBCA-lipiodol 
mixture drastically increases with the increasing amount of the lipiodol. In contrast, 
the viscosity of the mixtures of IBCA with FEB2 or FPB2 is quite low over the whole 
mixing concentrations, slightly decreasing with the increasing amount of FEB2 or FPB2. 
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      Figure 2. Viscosities of mixtures of isobutyl cyanoacrylate (IBCA) and contrast 
              media with various compositions; (A) hexafluorodibromopropane, (^) 
               tetrafluorodibromoethane, and (a) lipiodol ultra-fluide. 
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Set time 
   We determined the set time of the mixtures by dropping them in blood. The 
reason why we chose this special method among many possible ways to determine the 
set time was that dropping the mixtures in blood was fairly close to the clinical 
application of the embolizing material. Another method with the steel test strips, 
which is generally used for determining the set time of instantaneous adhesives such as 
CA for industrial purposes, was also employed to estimate the set times of the mixtures 
in vitro. The set times of the mixtures of IBCA with the contrast media in blood are 
shown in Fig. 3. The set time of the IBCA-lipiodol mixture has a concentration 
dependence similar to that of the viscosity. The set time of the mixture increases 
steeply as the lipiodol concentration increases. The set time of the IBCA and 
iophendylate mixture reported by Cromwell et  al." was given in Fig. 3 for comparison. 
The set time change resulted upon adding iophendylate is not remarkable at least in the 
IBCA concentration range higher than about 30 wt%, but both BPFC (FEB2 and FPB2) 
have no effect on the polymerization of IBCA up to 80 wt% of the BPFC concentration 
in the mixtures. 
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       Figure 3. Set times of mixtures of isobutyl cyanoacrylate (IBCA) and contrast 
               media (in blood) with various compositions; (o) hexafluorodibromopro-
               pane, (^) tetrafluorodibromoethane, (0) lipiodol ultra-fluide, and (•) 
                iophendylate. 
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   The set times of the IBCA-FPB2 mixtures using the steel test strips are shown in 
Fig. 4. Interestingly, the set time of the IBCA-FPB2 mixture increases greatly as the 
FPB2 is added. This result is different from that obtained from the experiment done in 
blood. The reason is not clear to us at present, but it seems that the set times in blood 
are apparent polymerization times, while those measured with steel test strips are 
basically the times until to complete polymerization. 
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     Figure 4. Set times of mixtures of isobutyl cyanoacrylate (IBCA) and hexafluoro-
              dibromopropane with various compositions (steel test strips). 
Radiopacity 
   Balloon catheters filled with the mixtures of various compositions of IBCA and 
FPB2 were superimposed over a normal human skull and the roentgen photograph was 
taken. The result is shown in Fig. 5. The ratios of IBCA to FPB2 are 10:0, 8:2, 7:3, 
6:4, and 5:5. It is seen that the best radiopacity is obtained with the 5:5 IBCA-FPB2 
mixture. In Fig. 6, the radiopacity of the mixture is compared with the 5:5 IBCA-FEB2 
mixture. As is apparent, they have almost the same radiopacity. 
Toxicity 
   As described above, the non-radiopacity of IBCA could be solved by adding FPB2 
or FEB2, but there is an important factor to examine before its clinical application. 
That is toxicity of FEB2 and FPB2. Thus, their acute toxicity was tested by oral 
administration to mice. The result is given in Table 1. The LD50 of FEB2 is found to 
be 0.626-2.5 g/kg and that of the FPB2 0.125-2.5 g/kg. The maximal administration 
dosage necessary for angiography is below 2-3 g/60kg and much lower than the LD50 
for both BPFC. It is likely that FEB2 may be safer than FPB2. 
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     Figure 5. Catheters superimposed over normal human skull. Catheters are filled 
               with mixtures of isobutyl cyanoacrylate and hexafluorodibromopropane 
             with various compositions; (A) 10:0, (B) 8:2,(C) 7:3, (D) 6:4, and (E) 5:5. 
Angiography 
   Fig. 7 shows an angiogram obtained for canine carotid artery after injecting the 5:5 
IBCA-FEB2 mixture. The mixture could be injected very easily into the artery, 
indicating that the mixture was able to reach even very small arteries. 
                          DISCUSSION 
   The viscosity as well as the set time of embolus agents are very important physical 
factors for successful embolization, since they are injected into small nidus of cerebral 
vascular lesion and must be solidified there as quickly as possible. In addition, the 
embolus agents should be radiopaque, but their set time should not be altered greatly on 
addition of a contrast medium. When CA is employed as the quickly polymerizable 
liquid, the contrast medium to be added should be able to be dispersed or dissolved in 
the lipophilic CA without retarding the polymerization. As CA needs moisture for the 
rapid polymerization, a lipophilic contrast medium applicable to CA is hard to find. So 
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       Figure 6. Catheters superimposed over normal human skull. Catheters are filled 
               with the 5:5 mixture of isobutyl cyanoacrylate and contrast media; (A) 
                tetrafluorodibromoethane and (B) hexafluorodibromopropane. 
far, only lipiodol and iophendylate have been used as contrast medium for CA, but 
iophendylate at present is not commercially available in Japan any more. There are 
other problems for both the contrast media as described above. The viscosity of the 
mixtures of CA with lipiodol and iophendylate increases with the increasing amount of 
the contrast media. On the contrary, the new BPFC has a low viscosity and its 
radiopacity is satisfactory. A large quantity of embolus agent is not allowed to be 
injected for embolization. As there has been significant advance in computor technolo-
gy and digital substraction angiography can be performed on embolization, it is possible 
to reduce the content of the contrast medium in embolus agent less than 50 wt%. The 
set time of the BPFC-IBCA mixture is shorter than that of other mixtures. A too short 
set time is not desirable, because of difficulty in handling at angiography, but retarding 
the polymerization is much easier than accelerating it. We have not found any problem 
yet at least for injecting this newly developed embolus agent into canine carotid arteries. 
   As far as the oral administration to mice is concerned, the new embolus agent from 
IBCA and BPFC do not provoke any acute toxic reactions. Relatively low boiling 
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      Figure 7. Angiogram of canine carotid artery after injecting the 5:5 isobutyl 
                cyanoacrylate and tetrafluorodibromoethane mixture.
               Table 1. Acute toxicity of Perbromoperifluorocarbons for 
                      JCL-ICR mice (oral administration). 
LDso 
      FEB20.63--2.5 g/kg 
37.5-150 g/60kg 
      FPB20.13-2.5 g/kg 
                      7.5-30 g/60kg 
points of BPFC are advantageous, because the contrast media will be rapidly excreted 
by exhalation. However, it is true that there must be some differences in LD50 
between the oral administration and the intraarterial injection. Moreover, it would be 
more complicated when the contrast medium is mixed with IBCA. Thus, a study for 
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toxicity of the embolus agents is in progress with intraarterial injection and other 
administration methods for dog. 
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